PIM1 Protein (Proviral Integration Site for Moloney Murine Leukemia Virus 1)

PIM1 Protein (Proviral Integration Site for Moloney Murine Leukemia Virus 1)

Overview

PIM1 (Proviral Integration Site for Moloney Murine Leukemia Virus 1) is a constitutively active serine/threonine kinase belonging to the PIM family of kinases. Originally discovered as a proto-oncogene frequently activated by retroviral insertion in murine leukemia models, PIM1 has emerged as a critical regulator of neuronal survival, synaptic plasticity, and cognitive function. The kinase is widely expressed throughout the central nervous system, with particularly high levels in the hippocampus, cortex, and basal ganglia. PIM1 participates in diverse signaling pathways that control cell survival, metabolism, and plasticity, making it a significant player in both development and disease contexts. Unlike most kinases, PIM1 lacks a regulatory domain and maintains constitutive activity, allowing rapid signal transduction in response to cellular stress and neurotrophic factors. The protein has garnered considerable attention for its dual role in promoting neuronal survival while also contributing to pathological features of neurodegenerative diseases, particularly through its interactions with tau protein and alpha-synuclein.

Protein Infobox

PIM1 Protein (Proviral Integration Site for Moloney Murine Leukemia Virus 1)

Overview

PIM1 (Proviral Integration Site for Moloney Murine Leukemia Virus 1) is a constitutively active serine/threonine kinase belonging to the PIM family of kinases. Originally discovered as a proto-oncogene frequently activated by retroviral insertion in murine leukemia models, PIM1 has emerged as a critical regulator of neuronal survival, synaptic plasticity, and cognitive function. The kinase is widely expressed throughout the central nervous system, with particularly high levels in the hippocampus, cortex, and basal ganglia. PIM1 participates in diverse signaling pathways that control cell survival, metabolism, and plasticity, making it a significant player in both development and disease contexts. Unlike most kinases, PIM1 lacks a regulatory domain and maintains constitutive activity, allowing rapid signal transduction in response to cellular stress and neurotrophic factors. The protein has garnered considerable attention for its dual role in promoting neuronal survival while also contributing to pathological features of neurodegenerative diseases, particularly through its interactions with tau protein and alpha-synuclein.

Protein Infobox

<div class="infobox infobox-protein">
<table>
<tr><th>Protein Name</th><td>Proviral Integration Site for Moloney Murine Leukemia Virus 1</td></tr>
<tr><th>Gene Symbol</th><td>[PIM1](/genes/pim1)</td></tr>
<tr><th>UniProt ID</th><td>[P11309](https://www.uniprot.org/uniprotkb/P11309/entry)</td></tr>
<tr><th>PDB Structures</th><td>1XJD, 2JSS, 2Y0N, 4ALU, 5DWR</td></tr>
<tr><th>Molecular Weight</th><td>34 kDa (313 aa)</td></tr>
<tr><th>Subcellular Localization</th><td>Cytoplasm, Nucleus</td></tr>
<tr><th>Brain Expression</th><td>High in hippocampus, cortex, striatum, cerebellum</td></tr>
<tr><th>Protein Family</th><td>PIM kinase family (PIM1, PIM2, PIM3)</td></tr>
<tr><th>Chromosome Location</th><td>6p21.1</td></tr>
</table>
</div>

Structural Features

PIM1 possesses a characteristic kinase domain architecture that distinguishes it from typical serine/threonine kinases. The protein contains:

Catalytic Domain Architecture

• N-terminal domain: Contains the hinge region connecting the N-lobe and C-lobe of the kinase domain. This region contributes to substrate recognition and binding affinity.
• ATP-binding pocket: Located between the N-terminal and C-terminal lobes. Unlike many kinases, PIM1 has a relatively small hydrophobic pocket that accommodates ATP with high affinity, explaining its constitutive activity.
• Activation loop: Contains key serine/threonine residues that are phosphorylated in other kinases but are constitutively active in PIM1 due to its unique structure.
• C-terminal domain: Forms the C-lobe of the kinase domain, providing structural stability and substrate positioning.

Unique Structural Properties

Unlike typical kinases, PIM1 lacks:

• Regulatory domain: No PH domain, SH2 domain, or other regulatory modules found in many signaling kinases
• Activation segment phosphorylation: The activation loop is not regulated by phosphorylation
• Autoinhibitory elements: No intramolecular inhibitory interactions

Post-Translational Modifications

PIM1 undergoes several regulatory modifications:

• Phosphorylation: Can be phosphorylated by other kinases on serine and threonine residues, though its catalytic activity is largely independent of phosphorylation state
• Ubiquitination: Regulates protein stability and turnover
• Sumoylation: Affects subcellular localization and activity

Normal Function

Cell Survival Signaling

PIM1 promotes cell survival through phosphorylation of multiple pro-survival substrates:

BAD Phosphorylation

PIM1 phosphorylates [BAD](/proteins/bad-protein) (Bcl-2-associated agonist of cell death) at serine 112, which disrupts the pro-apoptotic function of BAD by promoting its binding to 14-3-3 proteins and preventing it from inhibiting anti-apoptotic [Bcl-2](/proteins/bcl2-protein) family members. This pathway is particularly important in neurons, where BAD-mediated apoptosis contributes to neurodegeneration. The phosphorylation of BAD by PIM1 provides a critical survival signal that protects neurons from various apoptotic stimuli, including trophic factor withdrawal and oxidative stress[@fan2019].

FOXO Transcription Factor Regulation

PIM1 phosphorylates [FOXO1](/proteins/foxo1-protein) transcription factor, promoting its nuclear export and inactivation. Since FOXО transcription factors regulate expression of pro-apoptotic genes including BIM and PUMA, PIM1-mediated phosphorylation provides an additional survival mechanism. In neurons, this pathway helps maintain cellular homeostasis under stress conditions[@xu2019].

Mitochondrial Dynamics

PIM1 regulates mitochondrial function through phosphorylation of key proteins involved in fission and fusion:

• Mitochondrial fission: PIM1 influences Drp1-mediated fission through indirect mechanisms
• Mitochondrial fusion: Regulates Mfn1/2 and OPA1 activity
• Metabolic function: Affects ATP production and mitochondrial membrane potential

Synaptic Plasticity and Memory

PIM1 plays a critical role in synaptic plasticity, the cellular basis of learning and memory:

Long-Term Potentiation (LTP)

PIM1 is upregulated during LTP induction and contributes to the molecular consolidation of synaptic changes. The kinase phosphorylates proteins involved in AMPA receptor trafficking and synaptic scaffolding, enhancing synaptic strength. Studies using PIM1 knockout mice show deficits in LTP and impaired spatial memory formation[@wang2022].

Dendritic Spine Morphology

PIM1 regulates dendritic spine density and morphology through phosphorylation of cytoskeletal regulatory proteins. Loss of PIM1 leads to reduced spine density and abnormal spine shapes, while overexpression promotes spine formation. This function involves regulation of Rac1 and cofilin activity[@yang2022].

NMDA Receptor Signaling

PIM1 interacts with [NMDA receptor](/proteins/nmda-receptor) subunits and modulates receptor trafficking and signaling. This interaction is important for calcium influx during synaptic activity, which triggers downstream plasticity mechanisms[@jacobson2022].

Neurotrophic Factor Signaling

PIM1 is induced by neurotrophic factors including:

• Brain-derived neurotrophic factor (BDNF): Triggers PIM1 expression during synaptic activity
• Nerve growth factor (NGF): Promotes PIM1-mediated survival in peripheral neurons
• Glial cell line-derived neurotrophic factor (GDNF): Regulates PIM1 in dopaminergic neurons

Transcriptional Regulation

PIM1 can phosphorylate transcription factors and co-activators:

• STAT proteins: Participates in cytokine signaling
• Myc: Cooperates with Myc in transcriptional regulation
• p300/CBP: Modifies chromatin accessibility

Role in Disease

Alzheimer's Disease

PIM1 has complex and multifaceted involvement in Alzheimer's disease pathogenesis:

Tau Pathology

PIM1 directly phosphorylates tau protein at multiple sites relevant to AD pathology. The kinase can phosphorylate tau at serine 262, a site within the microtubule-binding domain that disrupts tau-microtubule interaction and promotes aggregation. Additionally, PIM1 contributes to tau phosphorylation at other AD-relevant sites including serine 396 and threonine 231. This pathological phosphorylation promotes tau aggregation into neurofibrillary tangles and disrupts normal tau function in axonal transport[@chen2020].

Amyloid-Beta Interaction

PIM1 expression is altered in response to amyloid-beta exposure. Studies show that amyloid-beta oligomers induce PIM1 expression in neurons, and this upregulation appears to be a compensatory neuroprotective response. However, chronic elevation of PIM1 may contribute to tau pathology and other disease mechanisms. PIM1 also mediates some of the toxic effects of amyloid-beta through its effects on survival signaling and synaptic function[@hu2018].

Neuroinflammation

PIM1 is involved in neuroinflammatory responses in AD. The kinase regulates microglial activation and cytokine production, contributing to the chronic neuroinflammation characteristic of AD. PIM1 expression in microglia is increased around amyloid plaques, where it may modulate the inflammatory microenvironment[@zhou2021].

Expression in AD Brain

Multiple studies have documented altered PIM1 expression in AD brain tissue. Immunohistochemical analyses show increased PIM1 in vulnerable brain regions including hippocampus and entorhinal cortex. This elevation correlates with disease severity and neuropathological burden. The cellular distribution shows PIM1 in both neurons and glia, with particularly high levels in neurons containing neurofibrillary tangles[@brown2019].

Therapeutic Implications

Given the involvement of PIM1 in multiple aspects of AD pathogenesis, the kinase represents a potential therapeutic target. However, the dual role of PIM1 in both promoting neuronal survival and contributing to pathology creates complexity for therapeutic targeting. Strategies under investigation include:

• PIM1 inhibitors: Small molecules that reduce pathological tau phosphorylation while preserving survival functions
• Modulation of PIM1 expression: Targeting upstream signaling that drives PIM1 elevation
• Combination approaches: Targeting PIM1 alongside other relevant pathways

Parkinson's Disease

PIM1 involvement in Parkinson's disease centers on dopaminergic neuron survival and alpha-synuclein pathology:

Dopaminergic Neuron Survival

PIM1 provides critical survival signals for dopaminergic neurons in the substantia nigra. The kinase is induced by GDNF and other neurotrophic factors that promote dopaminergic neuron survival. Loss of PIM1 in animal models exacerbates dopaminergic neuron loss, while overexpression provides neuroprotection. This suggests PIM1 as a potential therapeutic target for preserving dopaminergic neurons in PD[@liu2018].

Alpha-Synuclein Phosphorylation

PIM1 can phosphorylate alpha-synuclein at serine 129, a modification extensively studied in PD pathogenesis. While serine 129 phosphorylation is found in most Lewy bodies and may have complex effects on aggregation and toxicity, PIM1's contribution to this modification adds to the complex picture of alpha-synuclein pathology in PD[@liu2020].

Autophagy Regulation

PIM1 regulates autophagy, a cellular process critical for clearing damaged proteins and organelles. In PD, autophagy dysfunction contributes to alpha-synuclein accumulation. PIM1 can both promote and inhibit autophagy depending on context, making its net effect on protein clearance complex. Regulation of autophagy by PIM1 involves phosphorylation of key autophagy proteins and modulation of mTOR signaling[@chen2021].

Other Neurodegenerative Conditions

Huntington's Disease

PIM1 expression is altered in Huntington's disease models and may contribute to neuronal dysfunction. The kinase participates in mutant huntingtin toxicity pathways and could represent a therapeutic target.

Amyotrophic Lateral Sclerosis (ALS)

PIM1 has been implicated in motor neuron survival in ALS. Studies show altered PIM1 expression in ALS models and human tissue, though the precise role remains to be clarified.

Stroke and Ischemia

PIM1 provides neuroprotective effects in ischemic brain injury. Pre-conditioning paradigms that induce PIM1 expression lead to improved outcomes following stroke, suggesting PIM1 induction as a potential neuroprotective strategy.

Cancer (Oncogenic Functions)

While not directly relevant to neurodegeneration, PIM1 is well-characterized as an oncogene:

• Overexpressed in various hematological malignancies
• Promotes cell proliferation and survival
• Multiple PIM1 inhibitors have entered clinical trials for cancer

Therapeutic Targeting

PIM1 Inhibitors

Several PIM1 inhibitors have been developed for oncological applications and are being evaluated for neurodegenerative diseases:

Clinical-Stage Compounds

• SGI-1776: First PIM1 inhibitor to enter clinical trials for cancer; shows neuroprotective effects in pre-clinical models
• AZD1208: Potent PIM1/2/3 inhibitor; evaluated for CNS penetration
• PIM447: Dual PIM1/3 inhibitor with extended residency time

Pre-clinical and Tool Compounds

• Compound 15c: Highly selective PIM1 inhibitor with good brain penetration
• DAPK-PIM1 inhibitor: Dual-target approach combining DAPK and PIM1 inhibition

Challenges and Considerations

Therapeutic targeting of PIM1 for neurodegenerative diseases faces several challenges:

Dual Function Complexity

PIM1 promotes both neuronal survival (beneficial) and pathological processes (harmful). Selective modulation that preserves survival functions while reducing pathology represents a significant challenge.

Brain Penetration

Many PIM1 inhibitors have limited CNS penetration, necessitating development of brain-penetrant compounds for neurological applications.

Biomarker Development

Biomarkers to guide patient selection and monitor treatment response are needed for clinical development.

Alternative Therapeutic Approaches

Beyond direct kinase inhibition, other strategies include:

• Gene therapy: Modulating PIM1 expression levels
• Protein-protein interaction inhibitors: Targeting specific PIM1-substrate interactions
• Combination approaches: Targeting PIM1 alongside other relevant pathways

Brain Atlas Resources

• [Allen Human Brain Atlas - PIM1 Expression](https://human.brain-map.org/microarray/search/show?search_term=PIM1)
• [Allen Cell Type Atlas](https://celltypes.brain-map.org/)
• [BrainSpan Atlas of the Developing Human Brain](https://brainspan.org/)

Cross-Links

• [PIM1 Gene](/genes/pim1)
• [FOXO1 Protein](/proteins/foxo1-protein)
• [BAD Protein](/proteins/bad-protein)
• [Tau Protein](/proteins/tau)
• [Alpha-Synuclein](/proteins/alpha-synuclein)
• [FOXO Transcription Factors](/mechanisms/foxo-signaling)
• [Cell Survival Pathways](/mechanisms/cell-survival-pathways)
• [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

See Also

• [PIM Kinase Family](/proteins/pim-kinase-family) — Overview of PIM1, PIM2, and PIM3
• [Serine/Threonine Kinases](/proteins/serine-threonine-kinases) — Broader kinase classification
• [Neurotrophic Factor Signaling](/mechanisms/neurotrophic-factor-signaling) — BDNF, NGF, GDNF pathways
• [Apoptosis Pathways](/mechanisms/apoptosis-pathways) — Cell death mechanisms
• [Tau Phosphorylation](/mechanisms/tau-phosphorylation) — Kinases involved in tau pathology

External Links

• [UniProt: P11309](https://www.uniprot.org/uniprotkb/P11309/entry)
• [PDB: PIM1 Structures](https://www.rcsb.org/search?q=PIM1)
• [GeneCards: PIM1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=PIM1)
• [OMIM: PIM1](https://omim.org/entry/164020)

References